Randomized crossover clinical trial assesses XG, PPT, and XOS for improving symptoms of IBS, indicating potential for enhanced gut health.
Background: Irritable bowel syndrome (IBS) is highly prevalent and poses a significant clinical challenge. Gavidarm is a medical device containing xyloglucan (XG), pea protein and grape seed extract containing tannins (PPT) and xylo-oligosaccharides (XOS), which act synergistically to protect and strengthen the intestinal barrier.
No takes yet. Share an insight, caveat, or question.
Bradic et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: